Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection

Journal of Neuroimmunology

Volumn 211, Issue 1-2, 2009, Pages 66-72

  Shriver, Leah P ^a   Koudelka, Kristopher J ^a   Manchester, Marianne ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Blood brain barrier; Central nervous system; CPMV; Microglial cells; Nanoparticles; Targeting

Indexed keywords

IMMUNOGLOBULIN G; NANOCARRIER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; COWPEA MOSAIC VIRUS; DEGENERATIVE DISEASE; DRUG DISTRIBUTION; ENDOTHELIUM; FEMALE; IN VITRO STUDY; INFLAMMATORY INFILTRATE; MACROPHAGE; MICROGLIA; MOSAIC VIRUS; MOUSE; MURINE HEPATITIS CORONAVIRUS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS INFECTION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM INFECTIONS; COMOVIRUS; CORONAVIRUS INFECTIONS; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MURINE HEPATITIS VIRUS; NANOPARTICLES;

EID: 67349200288     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.03.015     Document Type: Article

References (26)

1. Bharali D.J., Klejbor I., Stachowiak E.K., Dutta P., Roy I., Kaur N., Bergey E.J., Prasad P.N., and Stachowiak M.K. Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 11539-11544
2. Dandekar A.A., Anghelina D., and Perlman S. Bystander CD8 T-cell-mediated demyelination is interferon-gamma-dependent in a coronavirus model of multiple sclerosis. Am. J. Pathol. 164 (2004) 363-369
3. Destito G., Yeh R., Rae C.S., Finn M.G., and Manchester M. Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. Chem. Biol. 14 (2007) 1152-1162
4. Huber J.D., Egleton R.D., and Davis T.P. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24 (2001) 719-725
5. Kanmogne G.D., Schall K., Leibhart J., Knipe B., Gendelman H.E., and Persidsky Y. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J. Cereb. Blood Flow Metab. 27 (2007) 123-134
6. Khor I.W., Lin T., Langedijk J.P., Johnson J.E., and Manchester M. Novel strategy for inhibiting viral entry by use of a cellular receptor-plant virus chimera. J. Virol. 76 (2002) 4412-4419
7. Kim T.S., and Perlman S. Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus. J. Virol. 79 (2005) 7113-7120
8. Koto T., Takubo K., Ishida S., Shinoda H., Inoue M., Tsubota K., Okada Y., and Ikeda E. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am. J. Pathol. 170 (2007) 1389-1397
9. Koudelka K.J., Rae C.S., Gonzalez M.J., and Manchester M. Interaction between a 54-kilodalton mammalian cell surface protein and cowpea mosaic virus. J. Virol. 81 (2007) 1632-1640
10. Lane T.E., and Buchmeier M.J. Murine coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends Microbiol. 5 (1997) 9-14
11. Lane T.E., Liu M.T., Chen B.P., Asensio V.C., Samawi R.M., Paoletti A.D., Campbell I.L., Kunkel S.L., Fox H.S., and Buchmeier M.J. A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J. Virol. 74 (2000) 1415-1424
12. Lavi E., Gilden D.H., Highkin M.K., and Weiss S.R. Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J. Virol. 51 (1984) 563-566
13. Lewis J.D., Destito G., Zijlstra A., Gonzalez M.J., Quigley J.P., Manchester M., and Stuhlmann H. Viral nanoparticles as tools for intravital vascular imaging. Nat. Med. 12 (2006) 354-360
14. Loscher W., and Potschka H. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog. Neurobiol. 76 (2005) 22-76
15. Lu W., Zhang Y., Tan Y.Z., Hu K.L., Jiang X.G., and Fu S.K. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J. Control. Release 107 (2005) 428-448
16. McLain L., Durrani Z., Wisniewski L.A., Porta C., Lomonossoff G.P., and Dimmock N.J. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus. Vaccine 14 (1996) 799-810
17. Muldoon L.L., Nilaver G., Kroll R.A., Pagel M.A., Breakefield X.O., Chiocca E.A., Davidson B.L., Weissleder R., and Neuwelt E.A. Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain. Am. J. Pathol. 147 (1995) 1840-1851
18. Persidsky Y., Ramirez S.H., Haorah J., and Kanmogne G.D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmune. Pharmacol. 1 (2006) 223-236
19. Rae C.S., Khor I.W., Wang Q., Destito G., Gonzalez M.J., Singh P., Thomas D.M., Estrada M.N., Powell E., Finn M.G., and Manchester M. Systemic trafficking of plant virus nanoparticles in mice via the oral route. Virology 343 (2005) 224-235
20. Rao K.S., Reddy M.K., Horning J.L., and Labhasetwar V. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 29 (2008) 4429-4438
21. Raty J.K., Liimatainen T., Wirth T., Airenne K.J., Ihalainen T.O., Huhtala T., Hamerlynck E., Vihinen-Ranta M., Narvanen A., Yla-Herttuala S., and Hakumaki J.M. Magnetic resonance imaging of viral particle biodistribution in vivo. Gene Ther. 13 (2006) 1440-1446
22. Singh P., Prasuhn D., Yeh R.M., Destito G., Rae C.S., Osborn K., Finn M.G., and Manchester M. Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo. J. Control. Release 120 (2007) 41-50
23. Suzuki M., and Svendsen C.N. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci. 31 (2008) 192-198
24. Wang F.I., Hinton D.R., Gilmore W., Trousdale M.D., and Fleming J.O. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab. Invest. 66 (1992) 744-754
25. Wang Q., Kaltgrad E., Lin T., Johnson J.E., and Finn M.G. Natural supramolecular building blocks. Wild-type cowpea mosaic virus. Chem. Biol. 9 (2002) 805-811
26. Zhou J., Stohlman S.A., Hinton D.R., and Marten N.W. Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J. Immunol. 170 (2003) 3331-3336